Disc Medicine, Inc. — Director's Dealing 2021

May 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-04-28

Reporting Person: Strapps Walter (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-29	Stock Option (Right to Buy)	$11.92	A	9000	Acquired	2031-04-29	Common Stock (9000)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of three years from the Grant Date, April 28, 2021, with 25% vesting on the Grant Date, and the remainder vesting in equal installments over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.